白血球去除療法市場規模、佔有率、成長分析，按類型、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球白血球分離療法市場規模為6,630萬美元，從2023年的7,187萬美元成長到2031年的1,3702萬美元，複合年成長率預計為8.40%。

由於血液疾病和自體免疫疾病的增加，全球白血球去除術市場正在顯著成長。這種選擇性分離白血球的過程在白血病和自體免疫疾病等疾病的治療中發揮重要作用，同時也推進了診斷方法。白血球分離系統的創新提高了此手術的有效性和安全性，增加了其作為可靠治療選擇的吸引力。然而，與所需設備和訓練有素的人員相關的意識有限和高成本可能會阻礙市場成長。有大量的治療機會，特別是在白血球去除術、個人化醫療和基於細胞的療法（如 CAR-T 細胞療法）的交叉領域。隨著醫療保健基礎設施的發展，對具有成本效益的解決方案的研究和投資有可能進一步擴大這一重要的市場領域。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究

白血球去除術市場規模：依類型

• 市場概況
• 一次性的
• 裝置
  • 離心分離機
  • 膜分離設備

白血球去除術市場規模：依應用分類

• 市場概況
• 研究用途
• 治療用途

白血球去除術市場規模：依最終用戶分類

• 市場概況
• 血液成分供應商和血液中心
• 學術研究所
• 製藥和生物技術公司
• 醫院及輸血中心

白血球去除術市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Terumo BCT
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• Asahi Kasei Corporation
• Macopharma SA
• Miltenyi Biotec
• Medica Spa
• Puriblood Medical Co. Ltd.
• Beijing ZKSK Technology Co. Ltd.
• SB-Kawasumi Laboratories, Inc.
• Nikkiso Co., Ltd.
• Charles River Laboratories International, Inc.
• Discovery Life Sciences, Inc.
• Precision for Medicine, Inc.
• StemExpress, LLC
• Lonza Group AG
• Caltag Medsystems Limited
• Stemcell Technologies
• Trina Bioreactives AG
• AcceGen
• First Choice Bio LLC

結論和建議

Global Leukapheresis Market size was valued at USD 66.3 million in 2022 and is poised to grow from USD 71.87 million in 2023 to USD 137.02 million by 2031, growing at a CAGR of 8.40% during the forecast period (2024-2031).

The global leukapheresis market is experiencing significant growth, driven by rising incidences of hematologic disorders and autoimmune diseases. This process of selectively separating white blood cells plays a crucial role in treating conditions like leukemia and autoimmune disorders while advancing diagnostic methods. Technological innovations in leukapheresis systems have improved procedure efficacy and safety, enhancing their appeal as a reliable therapeutic option. However, market growth could be hindered by limited awareness and high costs associated with the necessary equipment and trained personnel. Opportunities abound, especially in the intersection of leukapheresis and personalized medicine, as well as cell-based therapies like CAR T-cell treatment. As healthcare infrastructure develops, investment in research and cost-effective solutions could further expand this vital market sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Leukapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Leukapheresis Market Segmental Analysis

Global Leukapheresis Market is segmented by Type, Application, End User, and region. Based on Type, the market is segmented into Disposables, Devices. Based on Application, the market is segmented into Research Applications, Therapeutic Applications. Based on End User, the market is segmented into Blood component providers & blood centers, Academic & research institutes, Pharmaceutical & biotechnology companies, Hospitals & transfusion centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Leukapheresis Market

The global leukapheresis market is primarily driven by the growing prevalence of hematologic disorders, including leukemia and lymphoma. As the incidence of these conditions continues to rise, the demand for effective treatment options becomes increasingly critical. Leukapheresis is instrumental in managing elevated white blood cell counts associated with these disorders, as it facilitates the rapid removal of leukemic cells from the bloodstream. This procedure not only alleviates symptoms but also helps in preparing patients for further therapeutic interventions. Consequently, the increasing recognition of leukapheresis as a vital treatment option significantly fuels market growth in this sector.

Restraints in the Global Leukapheresis Market

The global leukapheresis market faces several challenges that may impede its growth. A significant factor is the limited awareness of both healthcare providers and patients regarding the advantages of leukapheresis procedures. This lack of knowledge highlights the need for comprehensive educational initiatives aimed at fostering a better understanding of this therapeutic option. Additionally, the high expenses associated with leukapheresis devices and consumables pose another barrier, especially in resource-limited environments. Moreover, the requirement for skilled healthcare professionals to conduct these procedures further complicates accessibility, underscoring the necessity for targeted strategies to improve awareness and affordability in the market.

Market Trends of the Global Leukapheresis Market

The global leukapheresis market is witnessing a significant trend towards integration with cell-based therapies, particularly chimeric antigen receptor (CAR) T-cell therapy. This approach allows for the efficient collection and genetic modification of patient-derived white blood cells, which are essential for developing effective treatments against cancer. As healthcare providers increasingly recognize the potential of combining leukapheresis with advanced cell therapies, demand for leukapheresis technologies is expected to surge. This synergy not only enhances treatment efficacy but also drives innovation in leukapheresis procedures, positioning it as a cornerstone in the evolving landscape of personalized cancer care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Leukapheresis Market Size by Type & CAGR (2024-2031)

• Market Overview
• Disposables
• Devices
  • Centrifugal Devices
  • Membrane Separators

Global Leukapheresis Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research Applications
• Therapeutic Applications

Global Leukapheresis Market Size by End User & CAGR (2024-2031)

• Market Overview
• Blood component providers & blood centers
• Academic & research institutes
• Pharmaceutical & biotechnology companies
• Hospitals & transfusion centers

Global Leukapheresis Market Size & CAGR (2024-2031)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Terumo BCT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica Spa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puriblood Medical Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing ZKSK Technology Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SB-Kawasumi Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Discovery Life Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision for Medicine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemExpress, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caltag Medsystems Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trina Bioreactives AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcceGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• First Choice Bio LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation